Data-Driven Decision-Making in Advanced Breast Cancer: HER2 and HER2-low Breast Cancer Updates

home / insights / data-driven-decision-making-in-advanced-breast-cancer-her2-and-her2-low-updates

Expert perspectives on the evolving treatment paradigm of HER2-expressing breast cancer and how learnings from recent clinical trials are impacting real-world practices.

Sara A. Hurvitz, MD, an expert on breast cancer

EP. 1: Overview on Treatment Options for HER2+ Breast Cancer

Aditya Bardia, MD, MPH;Sara A. Hurvitz, MD;Virginia G. Kaklamani, MD, DSc;Heather McArthur, MD, MPH;Shirley Michelle Shiller, DO
February 21st 2023

Expert panelists provide a broad overview on HER2+ breast cancer and review the evolving treatment armamentarium.

S. Michelle Shiller, DO, AP/CP, MGP, a molecular pathologist

EP. 2: Expert Perspectives on Defining HER2-Low Breast Cancer

Aditya Bardia, MD, MPH;Sara A. Hurvitz, MD;Virginia G. Kaklamani, MD, DSc;Heather McArthur, MD, MPH;Shirley Michelle Shiller, DO
February 21st 2023

Centered discussion on the advent of HER2-low breast cancer and how it is differentiated from HER2+ and HER2- disease.

Heather McArthur, MD, an expert on breast cancer

EP. 3: Optimizing Real-World Management of HER2-Low Breast Cancer

Aditya Bardia, MD, MPH;Sara A. Hurvitz, MD;Virginia G. Kaklamani, MD, DSc;Heather McArthur, MD, MPH;Shirley Michelle Shiller, DO
February 28th 2023

Comprehensive insight on evolving management strategies for patients diagnosed with HER2-low breast cancer.

Sara A. Hurvitz, MD, an expert on breast cancer

EP. 4: Potential Role for T-DXd in Early-Stage HER2-Low Breast Cancer

Aditya Bardia, MD, MPH;Sara A. Hurvitz, MD;Virginia G. Kaklamani, MD, DSc;Heather McArthur, MD, MPH;Shirley Michelle Shiller, DO
February 28th 2023

Panelists share a brief discussion on early-stage HER2-low breast cancer and identify treatment options available in that setting.

Virginia Kaklamani, MD, an expert on breast cancer

EP. 5: Advice for Community Physicians on Managing HER2+ Breast Cancer

Aditya Bardia, MD, MPH;Sara A. Hurvitz, MD;Virginia G. Kaklamani, MD, DSc;Heather McArthur, MD, MPH;Shirley Michelle Shiller, DO
March 7th 2023

Closing out their review on treatment strategies for HER2-expressing breast cancer, panelists share practical advice for the community setting.